Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-derived cardiomyocytes by Prondzynski, M, Krämer, E, Laufer, S, Shibamiya, A, Pless, O, Flenner, F, Müller, O, Münch, J, Redwood, C, Hansen, A, Patten, M, Eschenhagen, T, Mearini, G, Carrier, L

Activation of autophagy ameliorates cardiomyopathy in Mybpc3-targeted knockin mice by Singh, SR, Zech, ATL, Geertz, B, Reischmann-Düsener, S, Osinska, H, Prondzynski, M, Krämer, E, Meng, Q, Redwood, C, van der Velden, J, Robbins, J, Schlossarek, S, Carrier, L

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy by Prondzynski, M, Lemoine, MD, Zech, AT, Horváth, A, Di Mauro, V, Koivumäki, JT, Kresin, N, Busch, J, Krause, T, Krämer, E, Schlossarek, S, Spohn, M, Friedrich, FW, Münch, J, Laufer, SD, Redwood, C, Volk, AE, Hansen, A, Mearini, G, Catalucci, D, Meyer, C, Christ, T, Patten, M, Eschenhagen, T